747
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Measurement of the Quality of Life of Prolanis Hypertension Patients in Sixteen Primary Healthcare Centers in Pandeglang District, Banten Province, Indonesia, Using EQ-5D-5L Instrument

, ORCID Icon & ORCID Icon
Pages 1103-1109 | Published online: 06 Jul 2020
 

Abstract

Introduction

The prevalence of hypertension in Indonesia is increasing, not least in some peripheral areas, including in Pandeglang District, Banten Province. The government of Indonesia, through the Social Health Insurance Administration Body (BPJS Kesehatan) has launched a chronic disease management program (Prolanis) to achieve more optimal results in treating patients with chronic diseases, including hypertension.

Objective

This study aimed to measure the quality of life of Prolanis hypertension patients at the primary healthcare centers (PHCs) using EuroQol-5 Dimensions-5 Levels (EQ-5D-5L) instrument and taking pharmacists' counseling intervention into account. This study was conducted in 96 Prolanis patients, consisting of 48 patients from 8 PHCs who did not receive pharmacists' counseling intervention (control group) and 48 other patients from 8 different PHCs who received 4 times intervention (intervention group). This study was conducted in a period of 3 months (June–August 2019) in 16 sub-districts of Pandeglang District.

Methods

An experimental study design was applied by considering a purposive sampling method. Patients' quality of life were measured by using EQ-5D-5L instrument and its Indonesian value set. For data analysis, we applied the Kruskal–Wallis, Mann–Whitney, Wilcoxon, and Binomial tests to investigate the differences of patients' quality of life in both groups of control and intervention.

Results and Conclusions

The results showed that the average utility value of the intervention group experienced an improvement at each meeting (m1 = 51.25%; m2 = 66.25%; m3 = 84.17%; and m4 = 91.67%), while the control group experienced a lower and more fluctuative improvement than the intervention group (m1 = 65.42%; m2 = 70.42%; m3 = 80.42%; and m4 = 76.67%). The same results also occurred in the average value of visual analogue scale (VAS). There was a better improvement in the intervention group than in the control group.

Clinical Trial Registration Number

62/UN6.KEP/EC/2019.

Graphical Abstract

Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use:

https://youtu.be/e0ehLVzB4Ig

Data Sharing Statement

The data used in the analyses are available from the corresponding author on reasonable request.

Ethics

The ethical permission was obtained from the Ethics Committee of Universitas Padjadjaran, Indonesia (Registration number: 62/UN6.KEP/EC/2019) and this study was conducted in accordance with the Declaration of Helsinki.

Acknowledgments

This study was funded by the Ministry of Education and Culture, Republic of Indonesia (Grant number: 1827/UN6.3.1/LT/2020).

Disclosure

There are no conflicts of interest.